| [1] PubMed ID: | 32857725 |
| Disease Name: | Cholangiocarcinoma |
| Sample: | CCA tissues and cells |
| Dysfunction Pattern: | regulation[regulating miR-520c-3p/MYCN] |
| Validated Method: | qRT-PCR//Luciferase Report Assay//RIP//ChIP |
| Description: | In this study, HOXD-AS1 expression was significantly upregulated in CCA tissues and cells compared with control groups, respectively.SP1/HOXD-AS1/miR-520c-3p/MYCN plays a vital role in initiation and progression of CCA, and HOXD-AS1 is expected to be an efficient biomarker and therapeutic target. |
| Causality: | Yes |
| Causal Description: | Functionally, gain- and loss-of-function experiments demonstrated that HOXD-AS1 facilitated tumor proliferation, migration, invasion, EMT, stemness and drug resistance in vitro and in vivo. |
| Clinical-realted Application: | Increased HOXD-AS1 was markedly correlated with lymph node invasion, advanced TNM stage and poor survival of CCA patients. |